| Q3 (Sep '09) | 2008 | |
| Net profit margin | -3900.00% | -3254.55% |
| Operating margin | -3843.75% | -3312.12% |
| EBITD margin | - | -2906.06% |
| Return on average assets | -74.18% | -52.22% |
| Return on average equity | -410.64% | -81.09% |
| Employees | 3 | - |
| Stephen D. Barnhill M.D. | Chairman of the Board, Chief Executive Officer | |
| R. Scott Tobin | President, General Counsel, Director | |
| John A. Norris | Chief Operating Officer | |
| Hong Zhang Ph.D. | Senior Vice President - Computational Medicine | |
| Michael Hanbury | Director | |
| Joseph McKenzie | Director |